BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26261062)

  • 21. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality.
    St Sauver JL; Bielinski SJ; Olson JE; Bell EJ; Mc Gree ME; Jacobson DJ; McCormick JB; Caraballo PJ; Takahashi PY; Roger VL; Rohrer Vitek CR
    Am J Med; 2016 Oct; 129(10):1093-1099.e1. PubMed ID: 27155109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
    Dunnenberger HM; Crews KR; Hoffman JM; Caudle KE; Broeckel U; Howard SC; Hunkler RJ; Klein TE; Evans WE; Relling MV
    Annu Rev Pharmacol Toxicol; 2015; 55():89-106. PubMed ID: 25292429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
    Schwartz EJ; Issa AM
    Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
    Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
    Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Qatar.
    Elewa H; Alkhiyami D; Alsahan D; Abdel-Aziz A
    J Eval Clin Pract; 2015 Aug; 21(4):703-9. PubMed ID: 25929423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacogenomics - a cornerstone of Precision Medicine. Genomic Medicine Sweden analyses genotypes associated with serious drug toxicity or therapeutic failure].
    Eliasson E; Wadelius M
    Lakartidningen; 2021 May; 118():. PubMed ID: 33973222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.
    Lee YM; McKillip RP; Borden BA; Klammer CE; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2017 May; 27(5):179-189. PubMed ID: 28267054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
    Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
    J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.
    Tan-Koi WC; Lim ES; Teo YY
    Pharmacogenomics J; 2017 Mar; 17(2):121-127. PubMed ID: 26902540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opinion, experience and educational preferences concerning pharmacogenomics: an exploratory study of Quebec pharmacists.
    Meloche M; Kwon HJ; Letarte N; Bussières JF; Vadnais B; Hurlimann T; Lavoie A; Beauchesne MF; de Denus S
    Pharmacogenomics; 2020 Mar; 21(4):235-245. PubMed ID: 32077363
    [No Abstract]   [Full Text] [Related]  

  • 36. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
    Stanek EJ; Sanders CL; Taber KA; Khalid M; Patel A; Verbrugge RR; Agatep BC; Aubert RE; Epstein RS; Frueh FW
    Clin Pharmacol Ther; 2012 Mar; 91(3):450-8. PubMed ID: 22278335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Pharmacogenomics to Guide Proton Pump Inhibitor Therapy in Clinical Practice.
    Harris DM; Stancampiano FF; Burton MC; Moyer AM; Schuh MJ; Valery JR; Bi Y
    Dig Dis Sci; 2021 Dec; 66(12):4120-4127. PubMed ID: 33475867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
    Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
    Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
    Cecchin E; De Mattia E; Ecca F; Toffoli G
    Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.